NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 213 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $374,814 | +29.7% | 9,465 | +137.2% | 0.09% | +15.4% |
| Q1 2022 | $289,000 | -0.3% | 3,991 | +128.1% | 0.08% | -35.0% |
| Q2 2021 | $290,000 | +18.4% | 1,750 | +23.6% | 0.12% | -19.5% |
| Q4 2020 | $245,000 | +9.4% | 1,416 | -24.4% | 0.15% | -47.3% |
| Q2 2020 | $224,000 | -31.1% | 1,874 | -32.3% | 0.28% | +183.0% |
| Q4 2019 | $325,000 | – | 2,767 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |